Sizing of powders in inhalers with an Aerosizer® according to a mixed experimental factorial design

Journal of Aerosol Science

Volumn 35, Issue 4, 2004, Pages 509-527

  Mendes, P J ^a,b   Raposo, A ^a,b   Sousa, J M M ^b   Pinto, J F ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

Aerosizer; Dry powder inhaler; Factorial design; Montgomery technique; Salbutamol sulfate; Terbutaline sulfate

Indexed keywords

DRUG PRODUCTS; ELECTRIC POTENTIAL; MIXTURES; RESPIRATORS;

DEAGGLOMERATION; INHALERS;

POWDERS;

SALBUTAMOL SULFATE; TERBUTALINE; VENTOLIN ROTACAPS;

PHARMACEUTICAL INDUSTRY; POWDER;

ANALYTIC METHOD; ARTICLE; DRY POWDER; FACTORIAL ANALYSIS; INHALER; INTERMETHOD COMPARISON; MOLECULAR INTERACTION; PARTICLE SIZE; PRIORITY JOURNAL; SHEAR STRENGTH; VIBRATION;

EID: 1642587834     PISSN: 00218502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaerosci.2003.10.005     Document Type: Article

References (23)

1. Allen, T. (1990). Sampling and sizing from the atmosphere. In: T. Allen (Ed.), Particle size measurement (4th edn) (pp 112-115). New York, USA: Chapman & Hall.
2. Amherst process instruments, API Aerosizer LD, User Manual (V7.02), Hadley, MA, USA.
3. Armstrong, N. A., & James, K. C. (1996). Pharmaceutical experimental design and interpretation (pp. 131-167). London, UK: Taylor & Francis.
4. Barber, T. A. (1993). Particle population analysis. In: T. A. Barber (Ed.), Pharmaceutical particulate matter, analysis and control (pp. 281-298). Buffalo Grove, IL, USA: Interpharm Press.
5. Dunbar C. Dry powder formulations for inhalation. Drug Delivery Systems & Science. 2:2002;78-80.
6. Gonda, I. (1992). Targeting by deposition. In A. J. Hickey (Ed.), Pharmaceutical inhalation aerosol technology (pp. 61-82). New York, USA: Marcel Dekker Inc.
7. Hickey, A. J. (2002). Delivery of drugs by the pulmonary route. In G. S. Banker, & C. T. Rhodes (Eds.), Modern pharmaceutics (pp 484-490). New York, USA: Marcel Dekekr Inc.
8. Houzego P. Deaggregation mechanisms in dry powder inhaler. Drug Delivery Systems & Science. 2:2002;81-85.
9. Laitinen N., Juppo A.M. Measurement of pharmaceutical particles using a time-of-flight particle sizer. European Journal of Pharmaceutics and Biopharmaceutics. 55:2003;93-98.
10. ® for the real-time measurement of medical aerosols from pressurized Metered-Dose Inhaler (pMDI) systems Aerosol Science and Technology. 25:1996;411-423.
11. Mitchell J.P., Nagel M.W. Time of flight aerodynamic particle size analyzers. Their use and limitations for the evaluation of medical aerosols Journal of Aerosol Medicine. 12:1999;217-240.
12. Mitchell J.P., Nagel M.W., Archer A.D. Size analysis of a pressurized metered dose inhaler delivered suspension formulation by the API Aerosizer time-of-flight aerodynamic particle size analyzer. Journal of Aerosol Medicine. 12:1999;255-264.
13. Montgomery, D. C. (1996). Factorials with mixed levels. In: D. C. Montgomery (Ed.), Design and analysis of experiments (4th ed.) (pp. 461-465). New York, USA: Wiley.
14. Myers, R. H., & Montgomery, D. C. (1995). Response surface methodology: Process and product optimization using designed experiments (pp. 32-56). New York, USA: Wiley.
15. Nagel M.W., Wiersema K.J., Bates S.L., Mitchell J.P. Size analysis of a pressurized metered dose inhaler delivered solution formulation by an Aerosizer-LD time-of-flight aerosol particle size spectrometer. Journal of Aerosol Medicine. 15:2002;75-85.
16. Oskouie A.K., Noll K.E., Wang H.C. Determination of particle diameter and lumped density and shape factor using a three beam time-of-flight (TOF) instrument. Journal of Aerosol Science. 33:2002;1125-1138.
17. Oskouie A.K., Noll K.E., Wang H.C. Minimizing the effect of density in determination of particle aerodynamic diameter using a time-of-flight instrument. Journal of Aerosol Science. 34:2003;501-506.
18. Peters T.M., Vanderpool R.W., Wiener R.W. Methodology for measuring PM 2.5 separator characteristics using an Aerosizer. Aerosol Science & Technology. 34:2001;398-406.
19. Ramon M., Juan G., Ciscar M.A., Amrti-Bonmati E., Morcillo E.J., Main J. Influence of low temperature on bronchodilatation induced by terbutaline administered by metered dose or dry powder inhalers in asthmatics. Fundamentals of Clinical Pharmacology. 14:2000;133-138.
20. Srichana T., Brain A., Marriott C., Martin G.P. A study of drug-carrier interactions in dry powder inhaler formulations using the Andersen cascade impactor, X-ray microanalysis and time-of-flight aerosol beam spectrometry (TOFABS). Chemical Pharmaceutical Bulletin. 48:2000;167-174.
21. Thornburg J., Cooper S.J., Leith D. Counting efficiency of the API Aerosizer. Journal of Aerosol Science. 30:1998;479-488.
22. US Pharmacopoea 26 - The United States Pharmacopoeial Convention (2003). USP Convention, Rockville, MD, USA.
23. Wierlik H., Diepenmaat P., Damhuis R. Formulation of lactose for inhaled delivery systems. Pharmaceutical Technology Europe. 14:2002;47-52.